BRAIN Biotech Balance Sheet Health
Financial Health criteria checks 5/6
BRAIN Biotech has a total shareholder equity of €17.6M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €74.1M and €56.6M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €12.97m |
| Equity | €17.56m |
| Total liabilities | €56.59m |
| Total assets | €74.15m |
Recent financial health updates
Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?
Jun 29
Is BRAIN Biotech (ETR:BNN) A Risky Investment?
Feb 16Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt
Sep 13Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?
Feb 14Recent updates
Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 27% Bounce
Nov 12Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 50% Bounce
Sep 24BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch
Aug 06Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?
Jun 29BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate
Apr 19BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable
Mar 28Is BRAIN Biotech (ETR:BNN) A Risky Investment?
Feb 16Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt
Sep 13Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like
Mar 21Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?
Feb 14When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?
Jan 18How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 31
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?
Dec 10Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?
Nov 17Financial Position Analysis
Short Term Liabilities: BNN's short term assets (€30.6M) exceed its short term liabilities (€11.9M).
Long Term Liabilities: BNN's short term assets (€30.6M) do not cover its long term liabilities (€44.7M).
Debt to Equity History and Analysis
Debt Level: BNN is debt free.
Reducing Debt: BNN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BNN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BNN has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 5.5% each year